Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electrograms

Abbott Medical Devices1 site in 1 country16 target enrollmentFebruary 2014

ConditionsArrythmia

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Arrythmia
Sponsor: Abbott Medical Devices
Enrollment: 16
Locations: 1
Primary Endpoint: Correlation of ventricular activation patterns determined by 12-lead ECG and device IEGMs-based method
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The objective of this study will be to evaluate the ability of IEGMs (Signal recorded from implanted pacing leads) and pseudo ECGs (derived from various IEGMs) to characterize various electrical conduction patterns. Electroanatomic mapping data and 12 Lead ECG will also be collected to characterize electrical conduction patterns during standard electrophysiology exam.

Registry

clinicaltrials.gov

Start Date

February 2014

End Date

June 2016

Last Updated

4 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Abbott Medical Devices

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patient with SJM CRM device implanted for more than 90 days

Exclusion Criteria

•Suspicion of lead dislodgment

Outcomes

Primary Outcomes

Correlation of ventricular activation patterns determined by 12-lead ECG and device IEGMs-based method

Time Frame: Acute, intraoperative

Correlation coefficient between ventricular activation patterns determined by a traditional technique, 12-lead ECG based vs. device based IEGMs method.